Coupang
CPNG
14.81
+0.39
+2.70%
Coupang
US · CPNG
#793 by market cap
Listed 2021
14.81
+0.39
+2.70%
Live - 5344 symbols - heartbeat 15s ago
· 2026-10-08 07:48
Pre-market
14.65
-1.05%
After-hours
14.80
-0.07%
Overnight
14.75
-0.41%
- Market cap
- 26.62B
- P/E (TTM)i
- -34.44
- P/Bi
- 8.91
- EPSi
- 0.11
- Div yieldi
- 0.00%
- 52W posi
- 8%
Reader sentiment
Are you bullish or bearish on CPNG?
Anonymous reader poll. Unscientific, not investment advice.
✦ Quant Financial Health how this is computed
Fair
- Altman Z-Score is 2.95, in the 1.8-3.0 "grey zone".
- Most reliable for industrial/manufacturing companies; less meaningful for banks, insurers and other financials.
Revenue annual, last 8 years
Latest year +14.09% YoY
Margins
- Gross margin
- 29.37%
- Operating margin
- 1.37%
- Net margin
- 0.60%
Key ratios & quality
- Enterprise valuei
- 22.46B
- Altman Z-Scorei
- 2.95
Altman Z-Score below ~1.8 suggests financial distress risk, above ~3.0 suggests low risk; the model is most reliable for industrial/manufacturing companies and less meaningful for banks and other financial firms.
Income statement
| Line item | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|
| Revenue | 4.05B | 6.27B | 11.97B | 18.41B | 20.58B | 24.38B | 30.27B | 34.53B |
| Gross profit | 189.38M | 1.03B | 1.99B | 2.95B | 4.71B | 6.19B | 8.83B | 10.14B |
| Selling & admin expenses | -- | -- | -- | -- | -- | -- | -- | -- |
| Research & development | -- | -- | -- | -- | -- | -- | -- | -- |
| Operating profit | -1.05B | -641.92M | -515.99M | -1.49B | -112.00M | 473.00M | 436.00M | 473.00M |
| Pretax profit | -1.10B | -697.13M | -462.87M | -1.54B | -93.00M | 584.00M | 473.00M | 597.00M |
| Tax | 2.28M | -241.00K | 292.00K | 1.00M | -1.00M | -776.00M | 407.00M | 383.00M |
| Net profit | -1.10B | -696.89M | -463.16M | -1.54B | -92.00M | 1.36B | 66.00M | 214.00M |
| Basic EPS | -1 | 0 | 0 | -1 | 0 | 1 | 0 | 0 |
| Diluted EPS | -0.69 | -0.48 | -0.33 | -1.08 | -0.05 | 0.75 | 0.08 | 0.11 |
| Line item | 2025-03 | 2025-06 | 2025-09 | 2025-12 | 2026-03 | 2026-06 |
|---|---|---|---|---|---|---|
| Revenue | 7.91B | 8.52B | 9.27B | 8.84B | 8.50B | 8.86B |
| Gross profit | 2.32B | 2.56B | 2.72B | 2.54B | 2.30B | 2.49B |
| Selling & admin expenses | -- | -- | -- | -- | -- | -- |
| Research & development | -- | -- | -- | -- | -- | -- |
| Operating profit | 154.00M | 149.00M | 162.00M | 8.00M | -242.00M | -556.00M |
| Pretax profit | 216.00M | 194.00M | 165.00M | 22.00M | -255.00M | -533.00M |
| Tax | 102.00M | 163.00M | 70.00M | 48.00M | 11.00M | 37.00M |
| Net profit | 114.00M | 31.00M | 95.00M | -26.00M | -266.00M | -570.00M |
| Basic EPS | 0 | 0 | 0 | 0 | 0 | 0 |
| Diluted EPS | 0.06 | 0.02 | 0.05 | -0.01 | -0.15 | -0.32 |
Balance sheet
| Line item | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|
| Total current assets | -- | 2.16B | 2.84B | 5.64B | 5.83B | 7.89B | 8.99B | 9.69B |
| Cash & ST investments | -- | 1.22B | 1.25B | 3.49B | 3.51B | 5.24B | 5.88B | 6.32B |
| Inventory | -- | 631.74M | 1.16B | 1.42B | 1.66B | 1.67B | 2.10B | 2.26B |
| Total assets | -- | 3.23B | 5.07B | 8.64B | 9.51B | 13.35B | 15.34B | 17.79B |
| Total current liabilities | -- | 1.88B | 3.73B | 4.74B | 5.06B | 6.95B | 7.72B | 9.36B |
| Short-term debt | -- | 111.53M | 431.45M | 636.59M | 630.00M | 871.00M | 967.00M | 1.51B |
| Long-term debt | -- | 768.77M | 943.19M | 283.19M | 538.00M | 529.00M | 988.00M | 648.00M |
| Total liabilities | -- | 6,762,766,000.00 | 9,136,194,000.00 | 6,465,877,000.00 | 7,099,000,000.00 | 9,257,000,000.00 | 11,242,000,000.00 | 13,164,000,000.00 |
| Total equity | -- | -3.53B | -4.07B | 2.18B | 2.41B | 4.09B | 4.10B | 4.62B |
| Retained earnings | -- | -3.57B | -4.11B | -5.65B | -5.74B | -4.38B | -4.23B | -4.02B |
| Line item | 2025-03 | 2025-06 | 2025-09 | 2025-12 | 2026-03 | 2026-06 |
|---|---|---|---|---|---|---|
| Total current assets | 9.21B | 10.18B | 10.81B | 9.69B | 9.36B | 9.26B |
| Cash & ST investments | 6.11B | 6.80B | 7.23B | 6.32B | 6.30B | 6.11B |
| Inventory | 2.05B | 2.29B | 2.49B | 2.26B | 2.04B | 2.07B |
| Total assets | 15.99B | 17.83B | 18.67B | 17.79B | 17.40B | 17.39B |
| Total current liabilities | 7.91B | 9.37B | 10.19B | 9.36B | 9.62B | 10.64B |
| Short-term debt | 1.00B | 1.46B | 1.89B | 1.51B | 2.23B | 2.55B |
| Long-term debt | 1.00B | 850.00M | 618.00M | 648.00M | 617.00M | 618.00M |
| Total liabilities | 11,588,000,000.00 | 13,146,000,000.00 | 13,927,000,000.00 | 13,164,000,000.00 | 13,469,000,000.00 | 14,407,000,000.00 |
| Total equity | 4.40B | 4.69B | 4.74B | 4.62B | 3.93B | 2.99B |
| Retained earnings | -4.12B | -4.09B | -4.00B | -4.02B | -4.29B | -4.86B |
Cash flow
| Line item | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|
| Operating cash flow | -694.47M | -311.84M | 301.55M | -411.00M | 565.00M | 2.65B | 1.89B | 1.77B |
| Depreciation & amortization | 53.62M | 70.91M | 127.52M | 201.00M | 231.00M | 275.00M | 433.00M | 517.00M |
| Free cash flow | -787.87M | -529.67M | -183.08M | -1.09B | -259.00M | 1.76B | 1.01B | 522.00M |
| Dividends paid | -- | -- | -- | -- | -- | -- | -- | -- |
| Stock buybacks / issuance | 548.20M | -114.61M | -97.04M | 3.43B | 0 | 0 | -178.00M | -243.00M |
| Ending cash balance | 739.91M | 1.37B | 1.40B | 3.81B | 3.69B | 5.60B | 6.03B | 6.41B |
| Line item | 2025-03 | 2025-06 | 2025-09 | 2025-12 | 2026-03 | 2026-06 |
|---|---|---|---|---|---|---|
| Operating cash flow | 354.00M | 545.00M | 792.00M | 82.00M | 184.00M | 367.00M |
| Depreciation & amortization | 122.00M | 126.00M | 133.00M | 136.00M | 143.00M | 145.00M |
| Free cash flow | 115.00M | 246.00M | 439.00M | -278.00M | -112.00M | 50.00M |
| Dividends paid | -- | -- | -- | -- | -- | -- |
| Stock buybacks / issuance | 0 | 0 | -81.00M | -162.00M | -391.00M | -459.00M |
| Ending cash balance | 6.20B | 6.89B | 7.32B | 6.41B | 6.39B | 6.20B |
Returns & efficiency
| Line item | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|
| ROE %i | -- | -- | -- | -- | -4.01 | 41.83 | 3.76 | 4.77 |
| ROA %i | -- | -23.79 | -14.31 | -22.50 | -1.01 | 11.90 | 1.07 | 1.26 |
| ROIC %i | -- | -- | -- | -- | -2.58 | 21.51 | 1.28 | 1.39 |
| 5-year avg ROE %i | -- | -- | -- | -- | -- | -- | -- | -- |
| EBIT margin %i | -25.27 | -9.57 | -3.07 | -8.13 | -0.32 | 2.59 | 2.03 | 1.98 |
| FCF / sales %i | -- | -- | -- | -- | -- | 7.20 | 3.33 | 1.51 |
| Current ratioi | -- | 1.15 | 0.76 | 1.19 | 1.15 | 1.14 | 1.17 | 1.04 |
| Quick ratioi | -- | 0.68 | 0.35 | 0.77 | 0.73 | 0.80 | 0.81 | 0.71 |
| Debt / assetsi | -- | 39.52 | 44.09 | 24.54 | 25.25 | 20.88 | 24.28 | 26.06 |
| LT debt / equityi | -- | -- | -- | 68.22 | 73.41 | 46.86 | 67.22 | 67.71 |
| Interest coveragei | -14.44 | -6.19 | -3.40 | -32.99 | -2.43 | 13.17 | 4.38 | 7.94 |
| Revenue CAGR (3Y) %i | -- | -- | -- | 65.59 | 48.60 | 26.77 | 18.03 | 18.83 |
| Net income CAGR (3Y) %i | -- | -- | -- | -- | -- | -- | -- | -- |
| FCF CAGR (3Y) %i | -- | -- | -- | -- | -- | -- | -- | -- |
| Line item | 2025-03 | 2025-06 | 2025-09 | 2025-12 | 2026-03 | 2026-06 |
|---|---|---|---|---|---|---|
| ROE %i | 6.06 | 8.55 | 8.73 | 4.77 | -3.97 | -19.99 |
| ROA %i | 1.66 | 2.21 | 2.23 | 1.26 | -0.99 | -4.35 |
| ROIC %i | 2.45 | 3.55 | 3.52 | 1.39 | -2.65 | -9.31 |
| 5-year avg ROE %i | -- | -- | -- | -- | -- | -- |
| EBIT margin %i | 2.47 | 2.93 | 2.86 | 1.98 | 0.58 | -1.48 |
| FCF / sales %i | 3.27 | 2.41 | 3.75 | 1.51 | 0.84 | 0.28 |
| Current ratioi | 1.16 | 1.09 | 1.06 | 1.04 | 0.97 | 0.87 |
| Quick ratioi | 0.83 | 0.78 | 0.75 | 0.71 | 0.69 | 0.61 |
| Debt / assetsi | 25.52 | 25.68 | 26.51 | 26.06 | 31.01 | 32.38 |
| LT debt / equityi | 70.45 | 66.60 | 64.52 | 67.71 | 80.59 | 103.38 |
| Interest coveragei | 5.63 | 7.62 | 8.76 | 7.94 | 2.66 | -6.91 |
| Revenue CAGR (3Y) %i | -- | -- | -- | -- | -- | -- |
| Net income CAGR (3Y) %i | -- | -- | -- | -- | -- | -- |
| FCF CAGR (3Y) %i | -- | -- | -- | -- | -- | -- |
✦ Quant Revenue Concentration how this is computed
Single-engine
- Product Commerce is the largest reported line at 83.84% of revenue, across 2 reported segments.
- The next-largest line, Developing Offerings, is a distant second at 16.16% - a sharp slowdown here would have little to offset it.
Revenue breakdown most recent period
Business
Product Commerce83.84%
Developing Offerings16.16%
Quote time 2026-10-08 07:48:03 · For reference only, not investment advice and not tailored to your situation.